Amedeo Smart

Free Medical Literature Service

 

Amedeo

Malaria
  Free Subscription

Articles published in
PLoS Med
    September 2024
  1. FADILAH I, Commons RJ, Chau NH, Chu CS, et al
    Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis.
    PLoS Med. 2024;21:e1004411.
    >> Share

    May 2024
  2. MOUSA A, Cuomo-Dannenburg G, Thompson HA, Chico RM, et al
    Measuring protective efficacy and quantifying the impact of drug resistance: A novel malaria chemoprevention trial design and methodology.
    PLoS Med. 2024;21:e1004376.
    >> Share

    January 2024
  3. PRICE DJ, Nekkab N, Monteiro WM, Villela DAM, et al
    Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission model.
    PLoS Med. 2024;21:e1004255.
    >> Share

    November 2023
  4. ZAW AS, Win ESS, Yan SW, Thein KS, et al
    Successful elimination of falciparum malaria following the introduction of community-based health workers in Eastern Myanmar: A retrospective analysis.
    PLoS Med. 2023;20:e1004318.
    >> Share

  5. WATSON JA, Peto TJ, White NJ
    Rectal artesunate suppositories for the pre-referral treatment of suspected severe malaria.
    PLoS Med. 2023;20:e1004312.
    >> Share

    April 2023
  6. SIGNORELL A, Awor P, Okitawutshu J, Tshefu A, et al
    Correction: Health worker compliance with severe malaria treatment guidelines in the context of implementing pre-referral rectal artesunate in the Democratic Republic of the Congo, Nigeria, and Uganda: An operational study.
    PLoS Med. 2023;20:e1004234.
    >> Share

    February 2023
  7. SIGNORELL A, Awor P, Okitawutshu J, Tshefu A, et al
    Health worker compliance with severe malaria treatment guidelines in the context of implementing pre-referral rectal artesunate in the Democratic Republic of the Congo, Nigeria, and Uganda: An operational study.
    PLoS Med. 2023;20:e1004189.
    >> Share

    October 2022
  8. TAYLOR SM, Korwa S, Wu A, Gree CL, et al
    Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
    PLoS Med. 2022;19:e1004104.
    >> Share

    September 2022
  9. PONS-DURAN C, Mombo-Ngoma G, Macete E, Desai M, et al
    Burden of malaria in pregnancy among adolescent girls compared to adult women in 5 sub-Saharan African countries: A secondary individual participant data meta-analysis of 2 clinical trials.
    PLoS Med. 2022;19:e1004084.
    >> Share

    May 2022
  10. NYAMWAYA DK, Otiende M, Mwango L, Kariuki SM, et al
    Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014-2018: A cohort study.
    PLoS Med. 2022;19:e1003994.
    >> Share

    January 2022
  11. PHYO AP, Dahal P, Mayxay M, Ashley EA, et al
    Clinical impact of vivax malaria: A collection review.
    PLoS Med. 2022;19:e1003890.
    >> Share

    October 2021
  12. BATTLE KE, Baird JK
    The global burden of Plasmodium vivax malaria is obscure and insidious.
    PLoS Med. 2021;18:e1003799.
    >> Share

    September 2021
  13. CAIRNS M, Ceesay SJ, Sagara I, Zongo I, et al
    Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in 5 countries.
    PLoS Med. 2021;18:e1003727.
    >> Share

  14. WECKMAN AM, Conroy AL, Madanitsa M, Gnaneswaran B, et al
    Neurocognitive outcomes in Malawian children exposed to malaria during pregnancy: An observational birth cohort study.
    PLoS Med. 2021;18:e1003701.
    >> Share

  15. HENDRIXSON DT, Smith K, Lasowski P, Callaghan-Gillespie M, et al
    A novel intervention combining supplementary food and infection control measures to improve birth outcomes in undernourished pregnant women in Sierra Leone: A randomized, controlled clinical effectiveness trial.
    PLoS Med. 2021;18:e1003618.
    >> Share

    June 2021
  16. DEVINE A, Battle KE, Meagher N, Howes RE, et al
    Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
    PLoS Med. 2021;18:e1003614.
    >> Share

  17. TONA LUTETE G, Mombo-Ngoma G, Assi SB, Bigoga JD, et al
    Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study.
    PLoS Med. 2021;18:e1003669.
    >> Share

    May 2021
  18. WOODFORD J, Gillman A, Jenvey P, Roberts J, et al
    Positron emission tomography and magnetic resonance imaging in experimental human malaria to identify organ-specific changes in morphology and glucose metabolism: A prospective cohort study.
    PLoS Med. 2021;18:e1003567.
    >> Share

  19. KHO S, Qotrunnada L, Leonardo L, Andries B, et al
    Evaluation of splenic accumulation and colocalization of immature reticulocytes and Plasmodium vivax in asymptomatic malaria: A prospective human splenectomy study.
    PLoS Med. 2021;18:e1003632.
    >> Share

    April 2021
  20. CHAVATTE JM, Snounou G
    Controlled human malaria infection-Maker and breaker of dogma.
    PLoS Med. 2021;18:e1003591.
    >> Share

  21. THRIEMER K, Ley B, von Seidlein L
    Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure.
    PLoS Med. 2021;18:e1003494.
    >> Share

  22. CHU CS, White NJ
    The prevention and treatment of Plasmodium vivax malaria.
    PLoS Med. 2021;18:e1003561.
    >> Share

  23. VON SEIDLEIN L, White NJ
    Taking on Plasmodium vivax malaria: A timely and important challenge.
    PLoS Med. 2021;18:e1003593.
    >> Share

  24. LEY B, Alam MS, Kibria MG, Marfurt J, et al
    Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case-control data from Bangladesh.
    PLoS Med. 2021;18:e1003576.
    >> Share

  25. NEKKAB N, Lana R, Lacerda M, Obadia T, et al
    Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study.
    PLoS Med. 2021;18:e1003535.
    >> Share

  26. AUBURN S, Cheng Q, Marfurt J, Price RN, et al
    The changing epidemiology of Plasmodium vivax: Insights from conventional and novel surveillance tools.
    PLoS Med. 2021;18:e1003560.
    >> Share

    November 2020
  27. HOSSAIN MS, Commons RJ, Douglas NM, Thriemer K, et al
    The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network.
    PLoS Med. 2020;17:e1003393.
    >> Share

  28. HOGAN AB, Winskill P, Ghani AC
    Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study.
    PLoS Med. 2020;17:e1003377.
    >> Share

    October 2020
  29. MOUSA A, Al-Taiar A, Anstey NM, Badaut C, et al
    The impact of delayed treatment of uncomplicated P. falciparum malaria on progression to severe malaria: A systematic review and a pooled multicentre individual-patient meta-analysis.
    PLoS Med. 2020;17:e1003359.
    >> Share

  30. STRESMAN G, Whittaker C, Slater HC, Bousema T, et al
    Quantifying Plasmodium falciparum infections clustering within households to inform household-based intervention strategies for malaria control programs: An observational study and meta-analysis from 41 malaria-endemic countries.
    PLoS Med. 2020;17:e1003370.
    >> Share

    September 2020
  31. HARTLEY MA, Hofmann N, Keitel K, Kagoro F, et al
    Clinical relevance of low-density Plasmodium falciparum parasitemia in untreated febrile children: A cohort study.
    PLoS Med. 2020;17:e1003318.
    >> Share

  32. LORENZ LM, Bradley J, Yukich J, Massue DJ, et al
    Comparative functional survival and equivalent annual cost of 3 long-lasting insecticidal net (LLIN) products in Tanzania: A randomised trial with 3-year follow up.
    PLoS Med. 2020;17:e1003248.
    >> Share

  33. O'BRIEN KS, Arzika AM, Maliki R, Manzo F, et al
    Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger.
    PLoS Med. 2020;17:e1003285.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016